EXEL
Price
$46.15
Change
+$1.85 (+4.18%)
Updated
Jul 3 closing price
Capitalization
12.59B
37 days until earnings call
RVMD
Price
$37.87
Change
+$0.68 (+1.83%)
Updated
Jul 3 closing price
Capitalization
7.05B
30 days until earnings call
Interact to see
Advertisement

EXEL vs RVMD

Header iconEXEL vs RVMD Comparison
Open Charts EXEL vs RVMDBanner chart's image
Exelixis
Price$46.15
Change+$1.85 (+4.18%)
Volume$6.04M
Capitalization12.59B
Revolution Medicines
Price$37.87
Change+$0.68 (+1.83%)
Volume$1.11M
Capitalization7.05B
EXEL vs RVMD Comparison Chart in %
Loading...
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXEL vs. RVMD commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXEL is a StrongBuy and RVMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (EXEL: $46.15 vs. RVMD: $37.87)
Brand notoriety: EXEL: Notable vs. RVMD: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXEL: 167% vs. RVMD: 44%
Market capitalization -- EXEL: $12.59B vs. RVMD: $7.05B
EXEL [@Biotechnology] is valued at $12.59B. RVMD’s [@Biotechnology] market capitalization is $7.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXEL’s FA Score shows that 2 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • EXEL’s FA Score: 2 green, 3 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, EXEL is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXEL’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 3 bullish TA indicator(s).

  • EXEL’s TA Score: 4 bullish, 3 bearish.
  • RVMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EXEL is a better buy in the short-term than RVMD.

Price Growth

EXEL (@Biotechnology) experienced а +7.10% price change this week, while RVMD (@Biotechnology) price change was +1.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

EXEL is expected to report earnings on Aug 12, 2025.

RVMD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXEL($12.6B) has a higher market cap than RVMD($7.05B). EXEL YTD gains are higher at: 38.589 vs. RVMD (-13.420). EXEL has higher annual earnings (EBITDA): 844M vs. RVMD (-776.65M). RVMD has more cash in the bank: 2.1B vs. EXEL (1.03B). RVMD has less debt than EXEL: RVMD (134M) vs EXEL (187M). EXEL has higher revenues than RVMD: EXEL (2.3B) vs RVMD (0).
EXELRVMDEXEL / RVMD
Capitalization12.6B7.05B179%
EBITDA844M-776.65M-109%
Gain YTD38.589-13.420-288%
P/E Ratio21.07N/A-
Revenue2.3B0-
Total Cash1.03B2.1B49%
Total Debt187M134M140%
FUNDAMENTALS RATINGS
EXEL: Fundamental Ratings
EXEL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
32
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EXELRVMD
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
63%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADRRX20.950.25
+1.21%
American Century Disciplined Growth R
PFPWX56.390.32
+0.57%
Parnassus Value Equity Institutional
CRMAX10.250.05
+0.49%
CRM Small/Mid Cap Value Inv
JGSRX13.060.06
+0.46%
JHancock Global Shareholder Yield R2
NZDJPY87.52N/A
N/A
New Zealand Dollar - Japan Yen

EXEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXEL has been loosely correlated with JAZZ. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if EXEL jumps, then JAZZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
+4.18%
JAZZ - EXEL
35%
Loosely correlated
-0.43%
RIGL - EXEL
29%
Poorly correlated
+1.50%
RVMD - EXEL
28%
Poorly correlated
+1.83%
CGON - EXEL
28%
Poorly correlated
+0.82%
UTHR - EXEL
28%
Poorly correlated
-0.25%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with ERAS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+1.83%
ERAS - RVMD
57%
Loosely correlated
-0.69%
CRNX - RVMD
55%
Loosely correlated
+1.22%
KYMR - RVMD
54%
Loosely correlated
+0.58%
RARE - RVMD
52%
Loosely correlated
+1.14%
OCUL - RVMD
52%
Loosely correlated
+1.69%
More